Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,326 | 5,433 | 2,857 | 1,387 | 1,369 |
| Depreciation Amortization | 1,407 | 1,020 | 680 | 332 | 1,339 |
| Income taxes - deferred | 524 | 414 | -13 | 289 | 390 |
| Accounts receivable | -576 | 322 | 691 | 9 | 2,691 |
| Accounts payable and accrued liabilities | 30 | -17 | -79 | -76 | -404 |
| Other Working Capital | -1,576 | -82 | -58 | -1,412 | -1,172 |
| Other Operating Activity | 2,124 | 802 | 436 | 414 | 1,605 |
| Operating Cash Flow | $11,258 | $7,892 | $4,514 | $943 | $5,818 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,390 | 950 | 950 | N/A | 884 |
| PPE Investments | -742 | -562 | -341 | -174 | -637 |
| Investing Cash Flow | $648 | $389 | $609 | $-174 | $247 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 623 | 86 | 23 | 3 | 1,730 |
| Other Financing Activity | -599 | -63 | -55 | -39 | -1,208 |
| Financing Cash Flow | $24 | $22 | $-32 | $-36 | $523 |
| Beginning Cash Position | 50,069 | 50,069 | 50,069 | 50,069 | 43,482 |
| End Cash Position | 62,000 | 58,372 | 55,160 | 50,802 | 50,069 |
| Net Cash Flow | $11,931 | $8,303 | $5,091 | $733 | $6,587 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,258 | 7,892 | 4,514 | 943 | 5,818 |
| Capital Expenditure | -742 | -562 | -341 | -174 | -637 |
| Free Cash Flow | 10,516 | 7,331 | 4,173 | 769 | 5,181 |